Approval · Notice of Compliance 19656 · 2017
SENSORCAINE: Notice of Compliance 19656
Issued August 15, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19656
- Date
- August 15, 2017
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE | 01976141 | Marketed |
| SENSORCAINE | 01976168 | Marketed |
| SENSORCAINE WITH EPINEPHRINE | 01976184 | Marketed |
| SENSORCAINE WITH EPINEPHRINE | 01976206 | Marketed |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML
- EPINEPHRINE BITARTRATE 5 MCG per ML